Cartesi Labs Ltd – Trademark Portfolio
Entity Type: 99
Cartesi Labs Ltd owns a portfolio of 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as CTSI, CARTESI, and HODL'EM. Of these, 10 are registered. The portfolio spans 4 Nice Classification classes, led by Class 42 (Computer & Scientific) and Class 36 (Insurance & Financial). Headquartered in Providence, Mahe.
Office No. 22 Alpha Centre
Providence, Mahe , SC
Showing of trademarks Trademarks
Trademark Classifications
Cartesi Labs Ltd's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Insurance; financial affairs; monetary affairs; real estate affairs
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Cartesi Labs Ltd have?
Cartesi Labs Ltd has 10 U.S. trademarks filed with the USPTO. Of these, 10 registered.
What trademark classes does Cartesi Labs Ltd file in?
Cartesi Labs Ltd files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 36 (Insurance & Financial), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Cartesi Labs Ltd's most well-known trademarks?
Cartesi Labs Ltd's registered trademark portfolio includes well-known marks such as CTSI, CARTESI, and HODL'EM. These are among 10 currently registered trademarks in the portfolio.
What is Cartesi Labs Ltd's trademark registration success rate?
Cartesi Labs Ltd has a 100% trademark registration rate, with 10 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.